Abstract: The present invention relates to a method of consuming a universal potent healing tonic. When consumed according to the method, of a host of medical ailments can be abated including cancer, arthritis, and insomnia.
Abstract: A method of making crystalline benzoyl peroxide particles having a particle size no greater than 25 microns and formed by wet milling in the absence of solvents and wherein the crystalline benzoyl peroxide is not irritating to the skin. A method of making a therapeutic or cosmetic composition comprising a water-based gel containing the crystalline benzoyl peroxide.
Type:
Grant
Filed:
February 12, 2014
Date of Patent:
July 7, 2015
Assignee:
Essential Ingredients, Inc.
Inventors:
Chris Gerlach, Mike Davies, Stephen M. Dawes
Abstract: Compounds of formula I wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts and all stereoisomers and tautomeric forms of the compounds of formula I can be used as insecticides and can be prepared in a manner known per se.
Type:
Grant
Filed:
June 27, 2012
Date of Patent:
June 23, 2015
Assignee:
Syngenta Participations AG
Inventors:
Roger Graham Hall, Andrew Edmunds, André Jeanguenat, Thomas Pitterna, Sebastian Rendler
Abstract: The present invention provides a reliable process for the preparation of polymorphic pure form A of Bazedoxifene x acetate. In addition, the present invention relates to a process of wet granulation of polymorphic pure form A of Bazedoxifene x acetate. The present invention also relates to pharmaceutical compositions comprising polymorphic pure form A of Bazedoxifene x acetate as well as to the use of cyclic ethers for the preparation of such pharmaceutical composition.
Type:
Grant
Filed:
December 21, 2011
Date of Patent:
June 23, 2015
Assignee:
SANDOZ AG
Inventors:
Arthur Pichler, Andreas Hotter, Christoph Langes
Abstract: A powder and gel concentrate for a sealing solution is provided. The concentrate is comprised of a biocide, dye and acid buffer. This concentrate can be hydrated or dissolved using standard tap (mineralized) water to produce a sealing solution. The acid buffer keeps the minerals in the tap water suspended in solution, thereby preventing the solid scale (mineral build-up) that would otherwise clog the filters of a sealing system.
Abstract: Compounds of the formula (I) or salts thereof, in each case in the optically active (3R,4R)-threo form, in which R1 is hydrogen or a hydrolysable radical, and (R2)n, (R3)m, n and m are as defined in formula (I) according to claim 1, where the stereochemical configuration at the carbon atom in position 3 of the butanoic acid derivative has a stereochemical purity of from 60 to 100% (R), preferably 70 to 100% (R), or more preferably 80 to 100% (R), in particular 90 to 100% (R), based on a mixture of threo enantiomers present, and the stereochemical configuration at the carbon atom in position 4 of the butanoic acid derivative has a stereochemical purity of from 60 to 100% (R), preferably 70 to 100% (R), more preferably 80 to 100% (R), in particular 90 to 100% (R), based on a mixture of threo enantiomers present, are suitable for use as herbicides and growth regulators, in particular for the selective use in plant crops, and can be prepared by the process of claim 9.
Type:
Grant
Filed:
March 12, 2012
Date of Patent:
June 9, 2015
Assignee:
Bayer Intellectual Property GmbH
Inventors:
Harald Jakobi, Marc Mosrin, Elmar Gatzweiler, Isolde Häuser-Hahn, Ines Heinemann, Christopher Hugh Rosinger, Alfred Angermann, Michael Gerhard Hoffmann, Stefan Schnatterer, Hans-Joachim Zeiβ
Abstract: The present invention relates to N-thio-anthranilamide compounds of the formula (I), the stereoisomers, the salts, the tautomers and the N-oxides thereof, wherein R1 is halogen or halomethyl; R2 is hydrogen, halogen or cyano; R3 is hydrogen, C1-C4 alkyl, C1-C4 haloalkyl, C2-C6-alkenyl or the like; R4 is halogen; R5 and R6 independently of each other are optionally substituted C1-C6-alkyl, C3-C6-cycloalkyl, C2-C6-alkenyl, C2-C6-alkynyl, phenyl, or together represent an (hetero)aliphatic chain, or the like; k is 0 or 1.
Type:
Grant
Filed:
August 10, 2012
Date of Patent:
June 2, 2015
Assignee:
BASF SE
Inventors:
Florian Kaiser, Karsten Körber, Prashant Deshmukh, Deborah L. Culbertson, Paul Neese, Koshi Gunjima
Abstract: The present invention relates to a pyridazinone compound of the formula (I): wherein R1 represents hydrogen, a C1-6 alkyl group, and the like, R2 represents halogen, a cyano group, a nitro group, a C1-6 alkoxy group, and the like, G represents hydrogen, and the like, Z represents halogen, a cyano group, a nitro group, a C1-6 alkyl group, and the like, and n represents an integer of 1-5 useful as an active ingredient in a herbicide and a noxious arthropod controlling agent.
Abstract: A pesticidal composition comprising 4-phenoxyphenyl 2-(2-pyridyloxy)propyl ether; a hydrophobic organic solvent capable of dissolving 0.1-fold by weight of 4-phenoxyphenyl 2-(2-pyridyloxy)propyl ether at 0° C.; polyvinyl alcohol; a nonionic surfactant selected from the group consisting of alkoxylated castor oil, alkoxylated hydrogenated castor oil and alkoxylated hydrogenated castor oil fatty acid ester; and water, is excellent in storage stability.
Abstract: Compounds which are trehalose-6-phosphate or trehalose-6-phosphonate precursors of formula (I) or agriculturally acceptable salts thereof are provided: (I) The compounds are useful in increasing starch production in plants.
Type:
Grant
Filed:
April 23, 2012
Date of Patent:
May 5, 2015
Assignee:
Isis Innovation Limited
Inventors:
Ram Sagar, Lucia F. Primavesi, Matthew J. Paul, Benjamin G. Davis
Abstract: Disclosed are compounds of Formula 1, N-oxides, and salts thereof, wherein Z is O or S; A1, A2, A3 and A4 are independently N or CR1, provided that only one of A1, A2, A3 and A4 is N; and R1, R2, R3 and Q are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling a parasitic nematode comprising contacting the parasitic nematode or its environment with a biologically effective amount of a compound or a composition of the invention.
Type:
Grant
Filed:
October 5, 2011
Date of Patent:
May 5, 2015
Assignee:
E I du Pont de Nemours and Company
Inventors:
George Philip Lahm, Thomas Francis Pahutski, Jr.
Abstract: The present invention generally relates to a method for minimizing the formation of insoluble salts of phenoxy herbicides. The method comprises (1) mixing a compatibility agent, amine salts of phenoxy acid herbicides, and a chemical containing non-amine cations in a aqueous system to form a stable and non-nozzle plugging solution; and (2) application of said stable and non-nozzle plugging solution onto target plants.
Type:
Grant
Filed:
March 30, 2007
Date of Patent:
April 21, 2015
Assignee:
Akzo Nobel N.V.
Inventors:
Jinxia Susan Sun, Shawn Zhu, Shuaib A. Khan
Abstract: There is disclosed herein a composition for treating extracellular parasitic infections, the composition comprising one or more of the following combinations: at least one quinolone or fluoroquinolone together with at least one tetracycline, iodoquinol, an azole or imidazole; or at least two agents selected from the group consisting of iodoquinol, thiazolidones, tetracycline, nitroimidazoles, cotrimoxazole and diloxanide furoate.
Abstract: A composite particle and a population of particles comprising a water-insoluble polyphosphate composition, methods of producing, and methods of using the same are provided. The polyphosphate composition may comprise at least one alkaline earth metal selected from calcium and magnesium and optionally at least one nutrient ion selected from the group consisting of potassium, ammonium, zinc, iron, manganese, copper, boron, chlorine, iodine, molybdenum, selenium or sulfur.
Abstract: A generally non-acidic hemostatic agent, having a relatively neutral pH comprising a magnesium compound, such as a magnesium chloride, a magnesium sulfate and/or a magnesium acetate based compound. The resultant agent is generally less caustic than previous agents, when using a similar amount of active material.
Abstract: Disclosed herein are cosmetic compositions comprising at least one film-forming polymer, at least one silicone elastomer blend, and at least one wax. Also disclosed herein are methods for making up and/or enhancing the appearance of a keratinous substrate comprising applying said composition to the keratinous substrate.
Type:
Grant
Filed:
December 31, 2012
Date of Patent:
March 31, 2015
Assignee:
L'Oreal
Inventors:
Kavita Patel, Angeles Fonolla-Moreno, Naoto Sugimoto
Abstract: An esteramide compound of the following formula (I): R1OOC-A-CONR2R3??(I) is described, wherein: A is a covalent bond or a methylene group —CH2—; R1 is an optionally substituted, saturated or unsaturated aliphatic or cycloaliphatic hydrocarbon group including from 5 to 36 carbon atoms, R2 and R3, either identical or different, are groups selected from a hydrogen atom, and optionally substituted hydrocarbon groups, preferably including from 1 to 36 carbon atoms, and R2 and R3 not being simultaneously hydrogen atoms. Also described, are applications for using the esteramide compound, notably as a solvent.
Abstract: Disclosed are compounds exhibiting sufficient herbicidal activity at low application dosage when they are applied to soils and foliage, and an agrochemical composition using the same, in particular herbicides. The compounds are triazine derivatives represented by following Formula 1 or salts thereof, and the herbicides containing them: [Chem. 28] wherein in the formula, R1 represents a hydrogen atom; a C1-C12 alkyl group; a C2-C6 alkenyl group, etc., R2 represents a C1-C12 alkyl group, etc., Y and Z represent an oxygen atom or a sulfur atom, and A represents a 5- or 6-membered cyclic group which may contain a nitrogen atom, an oxygen atom, or a sulfur atom.
Type:
Grant
Filed:
May 26, 2011
Date of Patent:
March 3, 2015
Assignees:
Kumiai Chemical Industry Co., Ltd., Ihara Chemical Industry Co., Ltd.
Abstract: The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, comprising: a) a cover layer, b) a reservoir present on the cover layer, comprising a polymer matrix comprising the active substance, c) an adhesive layer present on the reservoir comprising a contact adhesive, and d) a removable layer present on the adhesive layer, the active substance being rivastigmine, a physiologically compatible salt, hydrate, solvate or derivative thereof, characterized in that the polymer matrix of the reservoir comprises neither hydroxyl groups nor carboxyl groups.
Type:
Grant
Filed:
December 14, 2010
Date of Patent:
February 24, 2015
Assignee:
Acino AG
Inventors:
Heike Prinz, Björn Schurad, Thomas Beckert, Kristina Linder
Abstract: Conjugates comprising a N-oxime bond are disclosed. In one embodiment, a suitable conjugate is represented by the following Formula (I): wherein R? is derived from a compound comprising at least one reactive amide group, R? is derived from a compound comprising at least one reactive aminooxy group, and X is H, CnH(n+2) or other atoms. Additional methods are also provided.